The University of Rochester is participating in a new clinical trial through the National Institutes of Health, which will focus on mixing different manufacturers’ Covid-19 vaccines.
The trial will enroll patients who will be getting a booster dose of the vaccine in additions to the initial regime of an approved vaccine. The two doses are going to be from different manufacturers.
The point of this trial is to learn whether using different doses together cause any changes in the vaccines effectiveness regarding the long-term boost in immunity against the virus and the variants.
50 participants are needed in the Rochester, some who are not vaccinated and some who have been vaccinated within the last 12-20 weeks.
Anyone who would like to participate in the study can sign up online or call (585) 273-3990.
FingerLakes1.com is the region’s leading all-digital news publication. The company was founded in 1998 and has been keeping residents informed for more than two decades. Have a lead? Send it to [email protected].